Do Clinical and Immunohistochemical Findings of Pure Mucinous Breast Carcinoma Differ from Mixed Mucinous Breast Carcinoma ?

Erhan, Y.; Ciris, İbrahim; Zekioglu, O.; Erhan, Y.; Kapkac, M.; Makay, Oe.; Ozdemir, N.

doi:10.1080/00015458.2009.11680406

Do Clinical and Immunohistochemical Findings of Pure Mucinous Breast Carcinoma Differ from Mixed Mucinous Breast Carcinoma ?

Erhan Y., Ciris M., Zekioglu O., Erhan Y., Kapkac M., Makay O., ...Daha Fazla

ACTA CHIRURGICA BELGICA, cilt.109, sa.2, ss.204-208, 2009 (SCI-Expanded, Scopus)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 109 Sayı: 2
Basım Tarihi: 2009
Doi Numarası: 10.1080/00015458.2009.11680406
Dergi Adı: ACTA CHIRURGICA BELGICA
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
Sayfa Sayıları: ss.204-208
Süleyman Demirel Üniversitesi Adresli: Evet

Özet

Mucinous carcinoma of the breast is a relatively rare histologic type with two subtypes : pure and mixed. It has a favourable prognosis with a low risk of axillary metastases. The prognosis for pure mucinous carcinoma (PMC) was much better than for the mixed mucinous carcinoma (MMC). The aim of the study is to determine suitable candidates for breast or axillary conservation in mucinous carcinoma subtypes.